Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsCombined Modality TherapyCisplatinLeukemiaCyclophosphamideDoxorubicinTreatment OutcomeLeukemia, Myeloid, AcuteNeoadjuvant TherapyEtoposideDisease-Free SurvivalLeukemia, MyeloidBreast NeoplasmsSurvival AnalysisPrognosisNeoplasm StagingGene Expression Regulation, LeukemicSurvival RateLeukemia, LymphoidDrug Administration ScheduleMethotrexateLeukemic InfiltrationLung NeoplasmsCytarabineDrug Resistance, NeoplasmCarboplatinPaclitaxelInduction ChemotherapyVinblastinePrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm Recurrence, LocalTaxoidsAntimetabolites, AntineoplasticLeukemia, ExperimentalIfosfamideBone MarrowNeoplasmsDeoxycytidineBleomycinOrganoplatinum CompoundsTumor Cells, CulturedAnthracyclinesAntineoplastic Agents, AlkylatingSalvage TherapyFollow-Up StudiesChemotherapy, Cancer, Regional PerfusionTime FactorsDaunorubicinCarcinoma, Non-Small-Cell LungAntineoplastic Agents, PhytogenicTransplantation, AutologousCell Line, TumorAntibiotics, AntineoplasticLymphoma, Non-HodgkinOvarian NeoplasmsNeoplasm MetastasisNeutropeniaGranulocyte Colony-Stimulating FactorTesticular NeoplasmsVomitingApoptosisAdenocarcinomaNauseaNeoplastic Stem CellsRadiotherapy, AdjuvantHodgkin DiseaseHL-60 CellsDose-Response Relationship, DrugColorectal NeoplasmsRadiotherapyHematopoietic Stem CellsAntibodies, MonoclonalRecurrenceClinical Trials as TopicMitoxantroneCarmustineLeukemia, T-CellTumor Markers, BiologicalBlast CrisisProspective StudiesDacarbazineCamptothecinKaplan-Meier EstimateHematopoietic Stem Cell TransplantationNeoplasms, Germ Cell and EmbryonalLeukemia, Promyelocytic, AcuteLomustineBrain NeoplasmsAcute DiseaseLymphomaNeoplasm, ResidualPlatinum CompoundsBone NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Monocytic, AcuteInfusions, Intra-ArterialOsteosarcomaMelphalan